跳至主導覽
跳至搜尋
跳過主要內容
國立陽明交通大學研發優勢分析平台 首頁
English
中文
在 國立陽明交通大學研發優勢分析平台 搜尋內容
首頁
人員
單位
研究成果
計畫
獎項
活動
貴重儀器
影響
查看斯高帕斯 (Scopus) 概要
劉 嘉仁
副教授
急重症醫學研究所
電子郵件
chiajenliu
nycu.edu
tw
網站
https://bps.nycu.edu.tw/zh/faculty-members/%E5%8A%89%E5%98%89%E4%BB%81-chia-jen-liu/
h-index
h10-index
h5-index
8665
引文
52
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
3799
引文
31
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
209
引文
9
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2011
2026
每年研究成果
概覽
指紋
網路
研究成果
(242)
類似的個人檔案
(9)
指紋
查看啟用 Chia-Jen Liu 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Keyphrases
National Cohort Study
100%
Taiwan
44%
95% Confidence Interval
43%
Atrial Fibrillation
38%
Risk Factors
36%
Cancer Risk
24%
Hazard Ratio
24%
Standardized Incidence Ratio
24%
CHA2DS2-VASc Score
15%
Adjusted Hazard Ratio
15%
Ischemic Stroke
14%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
14%
Mycobacterium Tuberculosis (M. tb)
14%
Comorbidity
13%
Newly Diagnosed
13%
High Risk
12%
Atrial Fibrillation Patient
11%
Cancer Inpatients
11%
Taiwan National Health Insurance Research Database
11%
Ischemic Stroke Risk
10%
Multiple Myeloma
9%
Incidence Rate
9%
Independent Risk Factors
9%
Second Primary Malignancy
9%
National Health Insurance Research Database (NHIRD)
7%
Multivariate Analysis
7%
Chronic Obstructive Pulmonary Disease
7%
Prognostic Factors
7%
Multiple Myeloma Patients
7%
Overall Survival
7%
Radiotherapy
7%
New-onset Atrial Fibrillation
7%
Risk of Malignancy
7%
Chemotherapy
7%
Secondary Malignancy
7%
Bipolar Disorder
6%
Primary Central Nervous System Lymphoma (PCNSL)
6%
Population-based Study
6%
Hematopoietic Stem Cell Transplantation
6%
Adult Patients
6%
Taiwanese
6%
Newly Diagnosed multiple Myeloma
6%
Chronic Graft-versus-host Disease (cGVHD)
6%
Retrospective Cohort Study
6%
Early Mortality
6%
Oral Anticoagulants
5%
Asian Patients
5%
Low Risk
5%
Stroke Risk
5%
Acute Myocardial Infarction
5%
Medicine and Dentistry
Cohort Analysis
28%
Malignant Neoplasm
26%
Atrial Fibrillation
23%
Standardized Incidence Ratio
20%
Hazard Ratio
20%
Brain Ischemia
17%
Cancer
14%
Apoplexy
13%
Comorbidity
12%
CHA2DS2-VASc Score
12%
Multiple Myeloma
11%
Breast Cancer
11%
Radiation Therapy
11%
Second Cancer
9%
Bipolar Disorder
8%
Tuberculosis
8%
Risk Stratification
8%
Chemotherapy
8%
Proportional Hazards Model
7%
Chronic Obstructive Pulmonary Disease
6%
Primary Tumor
6%
Overall Survival
6%
Colorectal Carcinoma
6%
Odds Ratio
6%
Allogeneic Hematopoietic Stem Cell Transplantation
5%
Prognostic Factor
5%
Depressive Disorder
5%
Antithrombotic
5%
Leukemia
5%
Myocardial Infarction
5%
